187 related articles for article (PubMed ID: 26888431)
1. Chronic administration of an HDAC inhibitor treats both neurological and systemic Niemann-Pick type C disease in a mouse model.
Alam MS; Getz M; Haldar K
Sci Transl Med; 2016 Feb; 8(326):326ra23. PubMed ID: 26888431
[TBL] [Abstract][Full Text] [Related]
2. Tolerance of chronic HDACi treatment for neurological, visceral and lung Niemann-Pick Type C disease in mice.
Alam MS; Cooper B; Farris JD; Haldar K
Sci Rep; 2018 Mar; 8(1):3875. PubMed ID: 29497113
[TBL] [Abstract][Full Text] [Related]
3. Normalization of Hepatic Homeostasis in the
Munkacsi AB; Hammond N; Schneider RT; Senanayake DS; Higaki K; Lagutin K; Bloor SJ; Ory DS; Maue RA; Chen FW; Hernandez-Ono A; Dahlson N; Repa JJ; Ginsberg HN; Ioannou YA; Sturley SL
J Biol Chem; 2017 Mar; 292(11):4395-4410. PubMed ID: 28031458
[TBL] [Abstract][Full Text] [Related]
4. 2-Hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 disease.
Davidson J; Molitor E; Moores S; Gale SE; Subramanian K; Jiang X; Sidhu R; Kell P; Zhang J; Fujiwara H; Davidson C; Helquist P; Melancon BJ; Grigalunas M; Liu G; Salahi F; Wiest O; Xu X; Porter FD; Pipalia NH; Cruz DL; Holson EB; Schaffer JE; Walkley SU; Maxfield FR; Ory DS
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1545-1561. PubMed ID: 31051283
[TBL] [Abstract][Full Text] [Related]
5. The natural history of cerebellar degeneration of Niemann-Pick C mice monitored in vitro.
Marschalek N; Albert F; Meske V; Ohm TG
Neuropathol Appl Neurobiol; 2014 Dec; 40(7):933-45. PubMed ID: 24889722
[TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors correct the cholesterol storage defect in most Niemann-Pick C1 mutant cells.
Pipalia NH; Subramanian K; Mao S; Ralph H; Hutt DM; Scott SM; Balch WE; Maxfield FR
J Lipid Res; 2017 Apr; 58(4):695-708. PubMed ID: 28193631
[TBL] [Abstract][Full Text] [Related]
7. Intracisternal cyclodextrin prevents cerebellar dysfunction and Purkinje cell death in feline Niemann-Pick type C1 disease.
Vite CH; Bagel JH; Swain GP; Prociuk M; Sikora TU; Stein VM; O'Donnell P; Ruane T; Ward S; Crooks A; Li S; Mauldin E; Stellar S; De Meulder M; Kao ML; Ory DS; Davidson C; Vanier MT; Walkley SU
Sci Transl Med; 2015 Feb; 7(276):276ra26. PubMed ID: 25717099
[TBL] [Abstract][Full Text] [Related]
8. Reduced cerebellar neurodegeneration after combined therapy with cyclodextrin/allopregnanolone and miglustat in NPC1: a mouse model of Niemann-Pick type C1 disease.
Maass F; Petersen J; Hovakimyan M; Schmitt O; Witt M; Hawlitschka A; Lukas J; Rolfs A; Wree A
J Neurosci Res; 2015 Mar; 93(3):433-42. PubMed ID: 25400034
[TBL] [Abstract][Full Text] [Related]
9. Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease.
Alvarez AR; Klein A; Castro J; Cancino GI; Amigo J; Mosqueira M; Vargas LM; Yévenes LF; Bronfman FC; Zanlungo S
FASEB J; 2008 Oct; 22(10):3617-27. PubMed ID: 18591368
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of 2-Hydroxypropyl-β-cyclodextrin in Niemann-Pick Disease Type C Model Mice and Its Pharmacokinetic Analysis in a Patient with the Disease.
Tanaka Y; Yamada Y; Ishitsuka Y; Matsuo M; Shiraishi K; Wada K; Uchio Y; Kondo Y; Takeo T; Nakagata N; Higashi T; Motoyama K; Arima H; Mochinaga S; Higaki K; Ohno K; Irie T
Biol Pharm Bull; 2015; 38(6):844-51. PubMed ID: 26027824
[TBL] [Abstract][Full Text] [Related]
11. Decreased estradiol release from astrocytes contributes to the neurodegeneration in a mouse model of Niemann-Pick disease type C.
Chen G; Li HM; Chen YR; Gu XS; Duan S
Glia; 2007 Nov; 55(15):1509-18. PubMed ID: 17705200
[TBL] [Abstract][Full Text] [Related]
12. Decreased neural stem cell proliferation and olfaction in mouse models of Niemann-Pick C1 disease and the response to hydroxypropyl-β-cyclodextrin.
Dragotto J; Palladino G; Canterini S; Caporali P; Patil R; Fiorenza MT; Erickson RP
J Appl Genet; 2019 Nov; 60(3-4):357-365. PubMed ID: 31485950
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Analysis of the Proteome Response to the Histone Deacetylase Inhibitor (HDACi) Vorinostat in Niemann-Pick Type C1 disease.
Subramanian K; Rauniyar N; Lavalleé-Adam M; Yates JR; Balch WE
Mol Cell Proteomics; 2017 Nov; 16(11):1938-1957. PubMed ID: 28860124
[TBL] [Abstract][Full Text] [Related]
14. Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann-Pick Disease Type C Model Mice.
Fukaura M; Ishitsuka Y; Shirakawa S; Ushihama N; Yamada Y; Kondo Y; Takeo T; Nakagata N; Motoyama K; Higashi T; Arima H; Kurauchi Y; Seki T; Katsuki H; Higaki K; Matsuo M; Irie T
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466390
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of direct delivery of hydroxypropyl-beta-cyclodextrin to the lung by the nasal route in a mouse model of Niemann-Pick C1 disease: motor performance is unaltered and lung disease is worsened.
Erickson RP; Deutsch G; Patil R
J Appl Genet; 2018 May; 59(2):187-191. PubMed ID: 29411332
[TBL] [Abstract][Full Text] [Related]
16. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.
Ramirez CM; Liu B; Taylor AM; Repa JJ; Burns DK; Weinberg AG; Turley SD; Dietschy JM
Pediatr Res; 2010 Oct; 68(4):309-15. PubMed ID: 20581737
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Niemann--pick type C disease by histone deacetylase inhibitors.
Helquist P; Maxfield FR; Wiech NL; Wiest O
Neurotherapeutics; 2013 Oct; 10(4):688-97. PubMed ID: 24048860
[TBL] [Abstract][Full Text] [Related]
18. Polyrotaxane-based systemic delivery of β-cyclodextrins for potentiating therapeutic efficacy in a mouse model of Niemann-Pick type C disease.
Tamura A; Yui N
J Control Release; 2018 Jan; 269():148-158. PubMed ID: 29138063
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease.
Camargo F; Erickson RP; Garver WS; Hossain GS; Carbone PN; Heidenreich RA; Blanchard J
Life Sci; 2001 Nov; 70(2):131-42. PubMed ID: 11787939
[TBL] [Abstract][Full Text] [Related]
20. In Niemann-Pick C1 mouse models, glial-only expression of the normal gene extends survival much further than do changes in genetic background or treatment with hydroxypropyl-beta-cyclodextrin.
Marshall CA; Watkins-Chow DE; Palladino G; Deutsch G; Chandran K; Pavan WJ; Erickson RP
Gene; 2018 Feb; 643():117-123. PubMed ID: 29223359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
